Journal Home > Volume 7 , Issue 2

Stroke is the second leading cause of death and the main cause of long-term disability in the world. Therefore, treatment of the sequelae of stroke is one of the most important challenges in clinical neurotherapy. A 63-year-old Chinese woman with inarticulateness and right limb physical activity disorder for more than 4 months received olfactory ensheathing cells (OECs)-based neurorestorative therapy during the stay in hospital. Her neurological functions improved during 1-year follow-up. This case report showed that OECs therapy could be a treatment option for cerebral infarction sequela.


menu
Abstract
Full text
Outline
About this article

Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review

Show Author's information Xiaoling Guo1( )Xin Wang1,2Yan Li1Bo Zhou1,2Weidong Chen3Lihua Ren3
Department of Neurology, The 981st Hospital of the Chinese People's Liberation Army, Chengde 067000, Hebei, China
Chengde Medical University, Chengde 067000, Hebei, China
Otorhinolaryngology Department, The 981st Hospital of the Chinese People's Liberation Army, Chengde 067000, Hebei, China

Abstract

Stroke is the second leading cause of death and the main cause of long-term disability in the world. Therefore, treatment of the sequelae of stroke is one of the most important challenges in clinical neurotherapy. A 63-year-old Chinese woman with inarticulateness and right limb physical activity disorder for more than 4 months received olfactory ensheathing cells (OECs)-based neurorestorative therapy during the stay in hospital. Her neurological functions improved during 1-year follow-up. This case report showed that OECs therapy could be a treatment option for cerebral infarction sequela.

Keywords: stroke, cell therapy, olfactory ensheathing cell (OEC), Neurorestoratology

References(28)

[1]
Mangin G, Kubis N. Cell therapy for ischemic stroke: How to turn a promising preclinical research into a successful clinical story. Stem Cell Rev. 2019, 15(2): 176-193.
[2]
Baker EW, Kinder HA, West FD. Neural stem cell therapy for stroke: A multimechanistic approach to restoring neurological function. Brain Behav. 2019, 9(3): e01214. .
[3]
Augestad IL, Nyman AKG, Costa AI, et al. Effects of neural stem cell and olfactory ensheathing cell Co-transplants on tissue remodelling after transient focal cerebral ischemia in the adult rat. Neurochem Res. 2017, 42(6): 1599-1609.
[4]
Su ZD, He C. Olfactory ensheathing cells: biology in neural development and regeneration. Prog Neurobiol. 2010, 92(4): 517-532.
[5]
Shukla S, Chaturvedi RK, Seth K, et al. Enhanced survival and function of neural stem cells-derived dopaminergic neurons under influence of olfactory ensheathing cells in parkinsonian rats. J Neurochem. 2009, 109(2): 436-451.
[6]
Ma ZG, Stork T, Bergles DE, et al. Neuromodulators signal through astrocytes to alter neural circuit activity and behaviour. Nature. 2016, 539(7629): 428-432.
[7]
Dairaghi L, Flannery E, Giacobini P, et al. Reelin can modulate migration of olfactory ensheathing cells and gonadotropin releasing hormone neurons via the canonical pathway. Front Cell Neurosci. 2018, 12: 228.
[8]
Zhang JY, Chen HJ, Duan ZX, et al. The effects of Co- transplantation of olfactory ensheathing cells and schwann cells on local inflammation environment in the contused spinal cord of rats. Mol Neurobiol. 2017, 54(2): 943-953.
[9]
Khankan RR, Griffis KG, Haggerty-Skeans JR, et al. Olfactory ensheathing cell transplantation after a complete spinal cord transection mediates neuroprotective and immunomodulatory mechanisms to facilitate regeneration. J Neurosci. 2016, 36(23): 6269-6286.
[10]
Gómez RM, Sánchez MY, Portela-Lomba M, et al. Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs). Glia. 2018, 66(7): 1267-1301.
[11]
Yang H, He BR, Hao DJ. Biological roles of olfactory ensheathing cells in facilitating neural regeneration: a systematic review. Mol Neurobiol. 2015, 51(1): 168-179.
[12]
Xiao J, Chen L, Mao GS, et al. Neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells. J Neurorestoratology. 2017, 5: 175-179.
[13]
Caprio FZ, Sorond FA. Cerebrovascular disease. Med Clin N Am. 2019, 103(2): 295-308.
[14]
Zhong CK, Zhu ZB, Wang AL, et al. Multiple biomarkers covering distinct pathways for predicting outcomes after ischemic stroke. Neurology. 2019, 92(4): e295-e304.
[15]
Donkor ES. Stroke in the 21st century: A snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018, 2018: 3238165.
[16]
Jendelová P, Kubinová Š, Sandvig I, et al. Current developments in cell- and biomaterial-based approaches for stroke repair. Expert Opin Biol Ther. 2016, 16(1): 43-56.
[17]
Chen L, Xi HT, Huang HY, et al. Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke. Cell Transplant. 2013, 22(Suppl 1): S83-S91.
[18]
Guzman R, Choi R, Gera A, et al. Intravascular cell replacement therapy for stroke. Neurosurg Focus. 2008, 24(3/4): E15. .
[19]
Gopurappilly R, Pal R, Mamidi MK, et al. Stem cells in stroke repair: current success and future prospects. CNS Neurol Disord Drug Targets. 2011, 10(6): 741-756.
[20]
Roet KC, Franssen EH, de Bree FM, et al. A multilevel screening strategy defines a molecular fingerprint of proregenerative olfactory ensheathing cells and identifies SCARB2, a protein that improves regenerative sprouting of injured sensory spinal axons. J Neurosci. 2013, 33(27): 11116-11135.
[21]
Shapiro LA, Ng KL, Zhou QY, et al. Olfactory enrichment enhances the survival of newly Born cortical neurons in adult mice. Neuroreport. 2007, 18(10): 981-985.
[22]
Li C, Zhang B, Tian S, et al. Early wheel-running promotes functional recovery by improving mitochondria metabolism in olfactory ensheathing cells after ischemic stroke in rats. Behav Brain Res. 2019, 361: 32-38.
[23]
Chou RH, Lu CY, Lee W, et al. The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine. Cell Transplant. 2014, 23(4/5): 567-571.
[24]
Huang HY, Young W, Chen L, et al. Clinical cell therapy guidelines for neurorestoration (IANR/CANR 2017). Cell Transplant. 2018, 27(2): 310-324.
[25]
Huang HY, Chen L, Xi HT, et al. Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients (in Chinese). Chin J Repar Reconstruc Surg. 2009, 23(1): 14-20.
[26]
Giordana MT, Grifoni S, Votta B, et al. Neuropathology of olfactory ensheathing cell transplantation into the brain of two amyotrophic lateral sclerosis (ALS) patients. Brain Pathol. 2010, 20(4): 730-737.
[27]
Chen L, Huang HY, Xi HT, et al. Intracranial transplant of olfactory ensheathing cells in children and adolescents with cerebral palsy: a randomized controlled clinical trial. Cell Transplant. 2010, 19(2): 185-191.
[28]
Chen L, Huang HY, Xi HT, et al. A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries. Cell Transplant. 2014, 23(Suppl 1): S35-S44.
Publication history
Copyright
Rights and permissions

Publication history

Received: 10 April 2019
Revised: 17 May 2019
Accepted: 29 May 2019
Published: 03 June 2019
Issue date: June 2019

Copyright

© The authors 2019

Rights and permissions

This article is published with open access at http://jnr.tsinghuajournals.com

Return